We are live on ! Find out more
MIM

Monashee Investment Management Portfolio holdings

AUM $184M
1-Year Est. Return 197.43%
This Fund
S&P 500
This Quarter Est. Return
+18.44%
1 Year Est. Return
+197.43%
3 Year Est. Return
+447.04%
5 Year Est. Return
+479.31%
10 Year Est. Return
+5,610.42%
AUM
$845M
AUM Growth
+$279M
Cap. Flow
+$203M
Cap. Flow %
23.97%
Top 10 Hldgs %
63.74%
Holding
124
New
76
Increased
6
Reduced
15
Closed
19

Top Buys

Rank Stock Value
1
BUD icon
AB InBev
BUD
+$16.9M
2
SN icon
SharkNinja
SN
+$12.6M
3
AHR icon
American Healthcare REIT
AHR
+$9.21M
4
KSPI icon
Kaspi.kz JSC
KSPI
+$8.9M
5
ODD icon
ODDITY Tech
ODD
+$8.85M

Top Sells

Rank Stock Value
1
PCG icon
PG&E
PCG
+$4.69M
2
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$4.11M
3
GPCR icon
Structure Therapeutics
GPCR
+$4.1M
4
ARGX icon
argenx
ARGX
+$3.8M
5
LVS icon
Las Vegas Sands
LVS
+$3.69M

Sector Composition

Rank Sector Weight
1 Healthcare 15.07%
2 Industrials 5.62%
3 Consumer Staples 3.94%
4 Technology 3.82%
5 Consumer Discretionary 2.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AUTL
51
Autolus Therapeutics
AUTL
$551M
$3.14M 0.37%
+492,000
New +$3.07M
HUMA icon
52
Humacyte
HUMA
$201M
$3.11M 0.37%
+1,000,000
New +$3.36M
ALB.PRA icon
53
Albemarle Corp Depositary Shares
ALB.PRA
$2.53B
$2.95M 0.35%
+50,000
New +$2.81M
ABSI icon
54
Absci
ABSI
$1.53B
$2.84M 0.34%
+500,000
New +$2.25M
VTMX icon
55
Vesta Real Estate
VTMX
$3.18B
$2.75M 0.33%
70,000
+15,000
+27% +$560K
GEHC icon
56
GE HealthCare
GEHC
$32.9B
$2.73M 0.32%
+30,000
New +$2.5M
PGY icon
57
Pagaya Technologies
PGY
$1.8B
$2.5M 0.3%
+247,732
New +$3.52M
ADCT icon
58
ADC Therapeutics
ADCT
$144M
$2.25M 0.27%
+500,000
New +$1.84M
CDRE icon
59
Cadre Holdings
CDRE
$1.4B
$2.17M 0.26%
+60,000
New +$2.09M
LBPH
60
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
$2.16M 0.26%
+100,000
New +$2.18M
ADT icon
61
ADT
ADT
$5.49B
$2.15M 0.25%
+320,000
New +$2.13M
EOLS icon
62
Evolus
EOLS
$500M
$2.1M 0.25%
+150,000
New +$1.95M
CRGY icon
63
Crescent Energy
CRGY
$4.03B
$2.08M 0.25%
+175,100
New +$1.97M
ALPN
64
DELISTED
Alpine Immune Sciences Inc
ALPN
$2.08M 0.25%
52,546
-22,246
-30% -$656K
EYPT icon
65
EyePoint Inc
EYPT
$1.13B
$2.07M 0.24%
100,000
-75,000
-43% -$1.86M
PSBD icon
66
Palmer Square Capital BDC
PSBD
$320M
$2.04M 0.24%
+125,000
New +$2.04M
AS icon
67
Amer Sports
AS
$21B
$2M 0.24%
+122,831
New +$1.91M
TERN
68
DELISTED
Terns Pharmaceuticals
TERN
$1.97M 0.23%
+300,000
New +$1.96M
BILI icon
69
Bilibili
BILI
$7.95B
$1.96M 0.23%
+175,000
New +$1.83M
SWX icon
70
Southwest Gas
SWX
$6.56B
$1.9M 0.23%
+25,000
New +$1.62M
PYXS icon
71
Pyxis Oncology
PYXS
$243M
$1.89M 0.22%
+442,500
New +$1.86M
BBIO icon
72
BridgeBio Pharma
BBIO
$16.6B
$1.86M 0.22%
+60,000
New +$2.04M
TARS icon
73
Tarsus Pharmaceuticals
TARS
$2.97B
$1.82M 0.22%
+50,000
New +$1.47M
RGLS
74
DELISTED
Regulus Therapeutics
RGLS
$1.8M 0.21%
+625,000
New +$1.02M
NCDL icon
75
Nuveen Churchill Direct Lending
NCDL
$623M
$1.73M 0.21%
+95,963
New +$1.67M
1 2
3
4 5

Similar funds

SWMG
Sard Wealth Management Group Atlanta, Georgia $184M AUM 11.26% 1-Year Est. Return
IFPL
Investments & Financial Planning LLC Lexington, Kentucky $184M AUM 17.7% 1-Year Est. Return
RFG
RFP Financial Group Atlanta, Georgia $184M AUM 16.06% 1-Year Est. Return
NAM
Nutshell Asset Management Sevenoaks, United Kingdom $184M AUM 2.02% 1-Year Est. Return
GCGM
General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return
PSAMP
P. Schoenfeld Asset Management (PSAM) New York $184M AUM 97.09% 1-Year Est. Return
GCA
GSI Capital Advisors Newport Beach, California $184M AUM 5.17% 1-Year Est. Return
IVGAV
Index Venture Growth Associates V St. Helier, Jersey $184M AUM

Monashee Investment Management's Q1 2024 Portfolio in Review

As of Q1 2024, Monashee Investment Management held 124 positions worth $845M, up 49% from $567M the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Monashee Investment Management deployed $203M of net new capital in Q1 2024, opening 76 new positions and adding to 6 existing holdings. Its largest new stake was AB InBev: 270,100 shares worth $16.4M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 9.1% a quarter earlier, followed by Industrials and Consumer Staples.

On the sell side, the largest reduction was Vanguard FTSE Developed Markets ETF, an estimated $4.11M trimmed.

  • Monashee Investment Management's largest Q1 2024 buy was AB InBev: 270,100 shares worth $16.4M.
  • Monashee Investment Management added most to Vaxcyte in Q1 2024, an estimated $4.33M increase.
  • Monashee Investment Management's biggest Q1 2024 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $4.11M.
  • Monashee Investment Management fully exited PG&E in Q1 2024, selling an estimated $4.69M.
  • Monashee Investment Management's ten largest holdings make up 64% of its $845M portfolio in Q1 2024.
  • Monashee Investment Management opened 76 new positions and closed 19 in Q1 2024.
  • Monashee Investment Management's portfolio value rose 49% quarter-over-quarter to $845M.

Based on Monashee Investment Management's 13F filing for Q1 2024, filed 14 May 2024.